what are the long term effects of glp-1 Why do patients stop drugs? Millions of Americans have tried

Glucagon-like peptide 1 receptor agonists are not associated with an increased risk of ileus or intestinal obstruction in patients with inflammatory bowel disease: a danish nationwide cohort study

Experienced lawyers can help victims compile necessary documentation to support their claims

Strategies for managing constipation , bloating , headaches , and fatigue can help you tolerate higher doses without needing to reduce

Comorbidities diabetes, heart disease, or fatty liver disease may influence drug choice

82.0% of the patients were being treated with metformin HCl, 40.9% with insulin, 42.7% with a sulfonylurea, 16.8% with a DPP4 inhibitor, and 4.4% with a GLP-1 receptor agonist

GLP-1s are no longer just weight-loss drugs